The use of transcriptomic biomarkers for personalized medicine

Abstract

Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy… (More)
DOI: 10.1007/s10741-007-9004-7

Topics

9 Figures and Tables

Cite this paper

@article{Heidecker2007TheUO, title={The use of transcriptomic biomarkers for personalized medicine}, author={Bettina Heidecker and Joshua M Hare}, journal={Heart Failure Reviews}, year={2007}, volume={12}, pages={1-11} }